THE PRETREATMENT SERUM BETA-2-MICROGLOBULIN (BETA(2)M) IS THE MOST IMPORTANT FEATURE PREDICTING FREEDOM FROM PROGRESSION (FFP) IN CLINICALLY STAGED (CS) I-II HODGKINS-DISEASE (HD) TREATED WITH NOVP AND EXTENDED FIELD RADIOTHERAPY

Authors
HAGEMEISTER FB MCLAUGHLIN P RODRIGUEZ MA COX JD HA CS ROMAGUERA JE SARRIS A YOUNES A BACHIER C PRETI A CABANILLAS F
Citation
Fb. Hagemeister et al., THE PRETREATMENT SERUM BETA-2-MICROGLOBULIN (BETA(2)M) IS THE MOST IMPORTANT FEATURE PREDICTING FREEDOM FROM PROGRESSION (FFP) IN CLINICALLY STAGED (CS) I-II HODGKINS-DISEASE (HD) TREATED WITH NOVP AND EXTENDED FIELD RADIOTHERAPY, Blood, 86(10), 1995, pp. 2108-2108
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
86
Issue
10
Year of publication
1995
Supplement
1
Pages
2108 - 2108
Database
ISI
SICI code
0006-4971(1995)86:10<2108:TPSB(I>2.0.ZU;2-J